[go: up one dir, main page]

AU2908501A - Combination therapy for the treatment of inflammatory and respiratory diseases - Google Patents

Combination therapy for the treatment of inflammatory and respiratory diseases

Info

Publication number
AU2908501A
AU2908501A AU29085/01A AU2908501A AU2908501A AU 2908501 A AU2908501 A AU 2908501A AU 29085/01 A AU29085/01 A AU 29085/01A AU 2908501 A AU2908501 A AU 2908501A AU 2908501 A AU2908501 A AU 2908501A
Authority
AU
Australia
Prior art keywords
inflammatory
treatment
combination therapy
respiratory diseases
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29085/01A
Inventor
William Louis Macias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU2908501A publication Critical patent/AU2908501A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU29085/01A 2000-01-06 2000-12-22 Combination therapy for the treatment of inflammatory and respiratory diseases Abandoned AU2908501A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17475600P 2000-01-06 2000-01-06
US60174756 2000-01-06
PCT/US2000/034261 WO2001049315A1 (en) 2000-01-06 2000-12-22 Combination therapy for the treatment of inflammatory and respiratory diseases

Publications (1)

Publication Number Publication Date
AU2908501A true AU2908501A (en) 2001-07-16

Family

ID=22637397

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29085/01A Abandoned AU2908501A (en) 2000-01-06 2000-12-22 Combination therapy for the treatment of inflammatory and respiratory diseases

Country Status (5)

Country Link
EP (1) EP1251868A1 (en)
JP (1) JP2003519196A (en)
KR (1) KR20020063298A (en)
AU (1) AU2908501A (en)
WO (1) WO2001049315A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL374506A1 (en) 2001-10-15 2005-10-31 Chiron Corporation Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi)
KR20110017465A (en) * 2002-04-25 2011-02-21 더 스크립스 리서치 인스티튜트 Treatment and prevention of pulmonary disease symptoms
CN119638624A (en) * 2023-09-15 2025-03-18 上海壹迪生物技术有限公司 Neutrophil elastase inhibitor and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
JP3434326B2 (en) * 1992-08-25 2003-08-04 財団法人化学及血清療法研究所 Agent for prevention and treatment of adult respiratory distress syndrome (ARDS)

Also Published As

Publication number Publication date
EP1251868A1 (en) 2002-10-30
KR20020063298A (en) 2002-08-01
WO2001049315A1 (en) 2001-07-12
JP2003519196A (en) 2003-06-17

Similar Documents

Publication Publication Date Title
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
AU7186501A (en) Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
AU2003264282A1 (en) Phenethanolamine derivatives and their use in the treatment of respiratory diseases
AU1227302A (en) System and method for optimizing drug therapy for the treatment of diseases
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
AU2001249262A1 (en) Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
AU6083899A (en) Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
GB0004531D0 (en) The treatment of respiratory diseases
AU3840802A (en) Methods and compositions for the treatment of diseases of the eye
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU5611701A (en) Agent for the diagnosis and therapy of viral diseases
AU2728301A (en) Combination therapy for the treatment of inflammatory and respiratory diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU1405001A (en) Treatment of diseases
AU2001255168A1 (en) Compositions and methods for the treatment of immune related diseases
AU2002224905A1 (en) Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes
AU2002365654A1 (en) Treatment of diseases via the skin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase